These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 21176720)

  • 21. Increased teicoplanin doses are associated with improved serum levels but not drug toxicity.
    Matthews PC; Chue AL; Wyllie D; Barnett A; Isinkaye T; Jefferies L; Lovering A; Scarborough M
    J Infect; 2014 Jan; 68(1):43-9. PubMed ID: 24012820
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of Teicoplanin Trough Values After the Recommended Loading Dose in Children With Associated Safety Analysis.
    Yamada T; Kubota T; Yonezawa M; Nishio H; Kanno S; Yano T; Kobayashi D; Egashira N; Takada H; Hara T; Masuda S
    Pediatr Infect Dis J; 2017 Apr; 36(4):398-400. PubMed ID: 27977550
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of fluorescence polarization immunoassay and high-performance liquid chromatography methods for assay of teicoplanin: can correlation be improved?
    Davani S; Bérard M; Royer B; Kantelip JP; Muret P
    Pathol Biol (Paris); 2004 Dec; 52(10):584-8. PubMed ID: 15596307
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Retrospective analysis of relationships among the dose regimen, trough concentration, efficacy, and safety of teicoplanin in Chinese patients with moderate-severe Gram-positive infections.
    Zhou L; Gao Y; Cao W; Liu J; Guan H; Zhang H; Shi Y; Lv W; Cheng L
    Infect Drug Resist; 2018; 11():29-36. PubMed ID: 29379306
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Teicoplanin therapeutic drug monitoring in critically ill patients: a retrospective study emphasizing the importance of a loading dose.
    Pea F; Brollo L; Viale P; Pavan F; Furlanut M
    J Antimicrob Chemother; 2003 Apr; 51(4):971-5. PubMed ID: 12654757
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of vancomycin and teicoplanin trough serum levels in patients with infected orthopedic devices: new data for old therapies.
    Lemaire X; Loiez C; Valette M; Migaud H; Dubreuil L; Yazdanpanah Y; Senneville E
    J Infect Chemother; 2011 Jun; 17(3):370-4. PubMed ID: 21053041
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Optimal Trough Concentration of Teicoplanin in Febrile Neutropenic Patients with Hematological Malignancy.
    Sato Y; Hiramatsu K; Suzuki Y; Tanaka R; Kaneko T; Nonoshita K; Ogata M; Kadota JI; Itoh H
    Chemotherapy; 2018; 63(1):29-34. PubMed ID: 29169153
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Steady-state trough serum and epithelial lining fluid concentrations of teicoplanin 12 mg/kg per day in patients with ventilator-associated pneumonia.
    Mimoz O; Rolland D; Adoun M; Marchand S; Breilh D; Brumpt I; Debaene B; Couet W
    Intensive Care Med; 2006 May; 32(5):775-9. PubMed ID: 16550370
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tolerability and Plasma Drug Level Monitoring of Prolonged Subcutaneous Teicoplanin Treatment for Bone and Joint Infections.
    El Samad Y; Lanoix JP; Bennis Y; Diouf M; Saroufim C; Brunschweiler B; Rousseau F; Joseph C; Hamdad F; Ait Amer Meziane M; Routier S; Schmit JL
    Antimicrob Agents Chemother; 2016 Oct; 60(10):6365-8. PubMed ID: 27458228
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Variability in protein binding of teicoplanin and achievement of therapeutic drug monitoring targets in critically ill patients: lessons from the DALI Study.
    Roberts JA; Stove V; De Waele JJ; Sipinkoski B; McWhinney B; Ungerer JP; Akova M; Bassetti M; Dimopoulos G; Kaukonen KM; Koulenti D; Martin C; Montravers P; Rello J; Rhodes A; Starr T; Wallis SC; Lipman J;
    Int J Antimicrob Agents; 2014 May; 43(5):423-30. PubMed ID: 24630304
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Teicoplanin in patients with acute leukaemia and febrile neutropenia: a special population benefiting from higher dosages.
    Pea F; Viale P; Candoni A; Pavan F; Pagani L; Damiani D; Casini M; Furlanut M
    Clin Pharmacokinet; 2004; 43(6):405-15. PubMed ID: 15086277
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Teicoplanin pharmacokinetics during albumin dialysis.
    Weiler S; Falkensammer G; Seger C; Joannidis M; Bellmann R
    Artif Organs; 2011 Oct; 35(10):969-71. PubMed ID: 21501193
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapeutic drug monitoring of the teicoplanin trough level after the loading doses in patients receiving venoarterial extracorporeal membrane oxygenation.
    Chen GJ; Lin SW; Tsai IL; Kuo CH; Wang JT; Hsieh SM
    J Formos Med Assoc; 2020 Jun; 119(6):1086-1092. PubMed ID: 31672434
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An initial dosing method for teicoplanin based on the area under the serum concentration time curve required for MRSA eradication.
    Kanazawa N; Matsumoto K; Ikawa K; Fukamizu T; Shigemi A; Yaji K; Shimodozono Y; Morikawa N; Takeda Y; Yamada K
    J Infect Chemother; 2011 Apr; 17(2):297-300. PubMed ID: 20714913
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An ultra-high pressure liquid chromatography-tandem mass spectrometry method for the quantification of teicoplanin in plasma of neonates.
    Begou O; Kontou A; Raikos N; Sarafidis K; Roilides E; Papadoyannis IN; Gika HG
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Mar; 1047():215-222. PubMed ID: 26896312
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Age- and gender-related differences in teicoplanin levels in paediatric patients.
    Strenger V; Hofer N; Rödl S; Hönigl M; Raggam R; Seidel MG; Dornbusch HJ; Sperl D; Lackner H; Schwinger W; Sovinz P; Benesch M; Urlesberger B; Urban C
    J Antimicrob Chemother; 2013 Oct; 68(10):2318-23. PubMed ID: 23702837
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A simplified chart for determining the initial loading dose of teicoplanin in critically ill patients.
    Yoshida S; Suzuki A; Ohmori T; Niwa T; Okada H; Suzuki K; Kobayashi R; Doi T; Kitaichi K; Matsuura K; Murakami N; Ogura S; Itoh Y
    Pharmazie; 2017 Jan; 72(1):53-57. PubMed ID: 29441898
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Variability in Trough Total and Unbound Teicoplanin Concentrations and Achievement of Therapeutic Drug Monitoring Targets in Adult Patients with Hematological Malignancy.
    Byrne CJ; Roberts JA; McWhinney B; Fennell JP; O'Byrne P; Deasy E; Egan S; Desmond R; Enright H; Ryder SA; D'Arcy DM; McHugh J
    Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28320714
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Teicoplanin measurement in patients with renal failure: comparison of fluorescence polarization immunoassay, microbiological assay, and high-performance liquid chromatographic assay.
    Awni WM; St Peter WL; Guay DR; Kenny MT; Matzke GR
    Ther Drug Monit; 1991 Nov; 13(6):511-7. PubMed ID: 1837630
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Albumin concentration significantly impacts on free teicoplanin plasma concentrations in non-critically ill patients with chronic bone sepsis.
    Brink AJ; Richards GA; Lautenbach EE; Rapeport N; Schillack V; van Niekerk L; Lipman J; Roberts JA
    Int J Antimicrob Agents; 2015 Jun; 45(6):647-51. PubMed ID: 25819167
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.